Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in funding
But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...
Amanda Mealing's solicitor reveals devastating cancer diagnosis after cocaine-fuelled crash
Casualty and Holby City star Amanda Mealing's solicitor has revealed the actress has been battling blood cancer as she ...
8 key drug patents expiring soon — and what it means for the market
Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...
Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
Blood cancers dominate CAR-T pipeline
Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...
Live Science on MSN3d
Simple blood tests could be the future of cancer diagnosis
Pancreatic cancer is another disease that could benefit from a blood-based diagnostic test. Unlike colon cancer, pancreatic ...
Nasdaq12d
Ionis Out-Licenses Rights for Rare Blood Cancer Drug to Ono
A rare blood cancer, PV is marked by the overproduction ... regulatory filings and marketing of the drug. The drug was granted fast track and orphan drug designations by the FDA last year in ...
AI 'fingerprint' technology could bring cancer drugs to patients in half the current time
Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to ...
Wānaka blood cancer patient, 36, to get cutting-edge CAR T-cell therapy in China - why experts want the therapy here
Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for cutting-edge treatment. The CAR T-cell therapy involves the col ...